Click Here to return To Results

 

Tetrabenazine as Antichorea Therapy in Huntington Disease, A Randomized Controlled Trial Neurol 66:366-372, Huntington Study Group, 2006 See this aricle in Pubmed Article Abstract Tetrabenazine (TBZ), at adjusted dosages of up to 100 mg/day, effectively lessens chorea in ambulatory patients with Huntington disease. TBZ should be dosed individually based on outgoing assessment of possible adverse side effects.

Related Tags

(click to filter results - removes previous filter) chorea chorea,treatment of Huntington's chorea tetrabenazine treatment of neurologic disorder

Click Here to return To Results